Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 8/2005

01-08-2005

Evaluation of Endoscopic Variceal Ligation (EVL) Versus Propanolol Plus Isosorbide Mononitrate/Nadolol (ISMN) in the Prevention of Variceal Rebleeding: Comparison of Cirrhotic and Noncirrhotic Patients

Authors: Shiv K. Sarin, MD, DM, Manav Wadhawan, MD, DM, Rajesh Gupta, DM, Hansa Shahi, DM

Published in: Digestive Diseases and Sciences | Issue 8/2005

Login to get access
Metadata
Title
Evaluation of Endoscopic Variceal Ligation (EVL) Versus Propanolol Plus Isosorbide Mononitrate/Nadolol (ISMN) in the Prevention of Variceal Rebleeding: Comparison of Cirrhotic and Noncirrhotic Patients
Authors
Shiv K. Sarin, MD, DM
Manav Wadhawan, MD, DM
Rajesh Gupta, DM
Hansa Shahi, DM
Publication date
01-08-2005
Publisher
Kluwer Academic Publishers-Plenum Publishers
Published in
Digestive Diseases and Sciences / Issue 8/2005
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-005-2877-1

Other articles of this Issue 8/2005

Digestive Diseases and Sciences 8/2005 Go to the issue

Erratum

Increased β-Adrenergic Sensitivity Correlates with Visceral Hypersensitivity in Patients with Constipation-Predominant Irritable Bowel Syndrome

OriginalPaper

Gastric Electrical Stimulation Significantly Increases Canine Lower Esophageal Sphincter Pressure

OriginalPaper

Celiac Disease in an Adult Turkish Population with Type 1 Diabetes Mellitus

OriginalPaper

Immunization Needs of Chronic Liver Disease Patients Seen in Primary Care Versus Specialist Settings

OriginalPaper

Duodenal Acid Clearance in Humans: Observations Made with Intraluminal Impedance Recording

OriginalPaper

Acid Challenge to the Human Esophageal Mucosa: Effects on Epithelial Architecture in Health and Disease
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits